Company Search:
Advanced Search
Sponsored Links
Caplin Point Laboratories Limited Company Snapshot
Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other companies in this sector in India: Astrazeneca Pharma India Ltd (2018 sales of 5.71 billion Indian Rupees [US$79.08 million] ), Novartis India Limited (5.64 billion Indian Rupees [US$78.10 million] of which 100% was Pharmaceuticals), and Neuland Laboratories Limited (5.27 billion Indian Rupees [US$73.05 million] ).

Sales Analysis. Caplin Point Laboratories Limited reported sales of 5.40 billion Indian Rupees (US$74.77 million) for the fiscal year ending March of 2018. This represents an increase of 34.4% versus 2017, when the company's sales were 4.02 billion Indian Rupees. Sales at Caplin Point Laboratories Limited have increased during each of the previous five years (and since 2013, sales have increased a total of 325%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Caplin Point Laboratories Limited
  Stock Performance Chart for Caplin Point Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 462.35
(Figures in Indian Rupees)
1 Week -9.2%   13 Weeks 13.9%  
4 Weeks 4.3%   52 Weeks -32.2%  
Caplin Point Laboratories Limited Key Data:
  Ticker: CAPLIPOINT Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 5,398,420,000
(Year Ending Jan 2019).
Employees: 980
  Currency: Indian Rupees Market Cap: 34,955,278,225
  Fiscal Yr Ends: March Shares Outstanding: 75,603,500
  Share Type: Ordinary Closely Held Shares: 54,775,333
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.